Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing. Issue 3 (7th June 2013)

• Record Type: Journal Article
• Authors: Majewski, Ian J; Mittempergher, Lorenza; Davidson, Nadia M; Bosma, Astrid; Willems, Stefan M; Horlings, Hugo M; de Rink, Iris; Greger, Liliana; Hooijer, Gerrit KJ; Peters, Dennis; Nederlof, Petra M; Hofland, Ingrid; de Jong, Jeroen; Wesseling, Jelle; Kluin, Roelof JC; Brugman, Wim; Kerkhoven, Ron; Nieboer, Frank; Roepman, Paul; Broeks, Annegien; Muley, Thomas R; Jassem, Jacek; Niklinski, Jacek; van Zandwijk, Nico; Brazma, Alvis; Oshlack, Alicia; van den Heuvel, Michel; Bernards, René
• Is Part Of: Journal of pathology. Volume 230:Issue 3(2013)
• Page Start: 270
• Page End: 276
• Publication Date: 2013-06-07
• Subjects: Pathology -- Periodicals; 616.07
• DOI: 10.1002/path.4209
• Languages: English
• ISSNs: 0022-3417

Abstract

<abstract abstract-type="main" id="path4209-abs-0001"> <title>Abstract</title> <p id="path4209-para-0001"> <bold>Oncogenic fusion genes that involve kinases have proven to be effective targets for therapy in a wide range of cancers. Unfortunately, the diagnostic approaches required to identify these events are struggling to keep pace with the diverse array of genetic alterations that occur in cancer. Diagnostic screening in solid tumours is particularly challenging, as many fusion genes occur with a low frequency. To overcome these limitations, we developed a capture enrichment strategy to enable high‐throughput transcript sequencing of the human kinome. This approach provides a global overview of kinase fusion events, irrespective of the identity of the fusion partner. To demonstrate the utility of this system, we profiled 100 non‐small cell lung cancers and identified numerous genetic alterations impacting <italic>fibroblast growth factor receptor 3</italic> (<italic>FGFR3</italic>) in lung squamous cell carcinoma and a novel <italic>ALK</italic> fusion partner in lung adenocarcinoma. © 2013 The Authors. Journal of Pathology published by John Wiley &amp; Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.</bold> </p> </abstract>